アラニジピン
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2017/09/05 18:22:54」(JST)
[Wiki en表示]
Aranidipine
|
|
Clinical data |
AHFS/Drugs.com |
International Drug Names |
Routes of
administration |
Oral |
ATC code |
|
Legal status |
Legal status |
- In general: ℞ (Prescription only)
|
Identifiers |
IUPAC name
- O5-methyl O3-(2-oxopropyl)
|
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
KEGG |
|
ChEMBL |
|
Chemical and physical data |
Formula |
C19H20N2O7 |
Molar mass |
388.37 g/mol |
3D model (JSmol) |
|
SMILES
-
CC1=C(C(C(=C(N1)C)C(=O)OCC(=O)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
|
InChI
-
InChI=1S/C19H20N2O7/c1-10(22)9-28-19(24)16-12(3)20-11(2)15(18(23)27-4)17(16)13-7-5-6-8-14(13)21(25)26/h5-8,17,20H,9H2,1-4H3 Y
-
Key:NCUCGYYHUFIYNU-UHFFFAOYSA-N Y
|
(verify) |
Aranidipine (INN, trade name Sapresta) is a calcium channel blocker.
English Journal
- [Efficacy and safety of aranidipine in Chinese patients with mild-to-moderate essential hypertension].
- Jiao Y1, Chen L, Zheng JT, Ke YN2, Wang Y, Yang HY, Jin H, Zhao XL, Liu MX, Wang L, Wang BY, Li DY.
- Zhonghua yi xue za zhi.Zhonghua Yi Xue Za Zhi.2013 Oct 22;93(39):3104-10.
- OBJECTIVE: To assess the efficacy and safety of aranidipine versus retard-released felodipine in Chinese patients with mild-to-moderate essential hypertension.METHODS: This was a multicenter, randomized, double-blind, placebo and active antihypertensive drug parallel-controlled study. After 2 weeks
- PMID 24417987
- [The effects of aranidipine on ambulatory blood pressures in patients with mild to moderate essential hypertension].
- Chen L1, Jiang H, Hua Q, Yang HY, Zheng JT, Jin H, Jiao Y, Wang Y, Sun RH, Ke YN.
- Zhonghua nei ke za zhi.Zhonghua Nei Ke Za Zhi.2013 Sep;52(9):749-52.
- OBJECTIVE: To evaluate the effect of aranidipine enteric-coated capsules on 24 h blood pressure and blood pressure variability (BPV) in patients with mild to moderate essential hypertension.METHODS: This was an open clinical trial with 2 weeks of placebo run-in period. A total of 74 patients with bl
- PMID 24314165
- Efficacy and safety of aranidipine enteric-coated tablets compared with amlodipine in Chinese patients with mild to moderate essential hypertension: a multicenter, randomized, double-blind, parallel-controlled clinical trial.
- Yan LR1, Li YS, Chen GL, Wang L, Pang HM, Wu SY, Yu J, Li HM, Lin YZ, Zhao RP, Fan CM.
- Journal of cardiovascular pharmacology.J Cardiovasc Pharmacol.2012 Jul;60(1):8-14. doi: 10.1097/FJC.0b013e318254a566.
- This is a multicenter, randomized, double-blind, parallel-controlled study, conducted in Chinese patients with mild to moderate essential hypertension. After a 2-week washout period, 236 eligible patients were randomly to receive aranidipine 5-10 mg/d (n = 118) or amlodipine 5-10 mg/d (n = 118) for
- PMID 22441301
Japanese Journal
- Inhibition of T-type and L-type Ca^<2+> currents by aranidipine, a novel dihydropyridine Ca^<2+> antagonist
- Distinct action of aranidipine and its metabolite on renal microvessels with special reference to renal protection
Related Links
- アラニジピン(Aranidipine)の検索ならお薬検索QLife(キューライフ)。お医者さんが処方する処方薬と、薬局で買える市販薬(OTC)、の効果と副作用、写真、添付文書、保管方法等を掲載。商品名だけでなく一般名や剤形、色などからも検索 ...
- アラニジピン aranidipineサプレスタ Sapresta ベック Bec アラニジピン aranidipineサプレスタ Sapresta ベック Bec
Related Pictures







★リンクテーブル★
[★]
- 英
- aranidipine
- 商
- サプレスタ、ベック
- 関
- 血圧降下剤